Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
advances in neurology
adverse drug reaction
aggrenox
air transport
Alberta Stroke Program Early CT score
algorithm
andexanet
aneurysm, intracranial
angiography, neurologic complications with
angiotensin-converting enzyme, inhibitors
anterior cerebral artery, occlusion of
anticoagulant, complications of
anticoagulant, reversal of
anticoagulant, treatment
anticoagulant, treatment in CVD
antihypertensive
aptiganel
arterial dissection
arterial dissection, basilar
arterial dissection, carotid
arterial dissection, recurrent
arterial dissection, vertebral
arterial perforation
Asians
aspirin
aspirin, dose of
ataxia
atorvastatin
atrial fibrillation
atrial fibrillation, risk stratification
atrial myxoma
atypical
AURORA
baroreceptors
BASICS trial
basilar artery occlusion
basilar artery plaque
basilar artery stenosis
BASIS trial
BEST trial
blacks
blood pressure
blood pressure after stroke
brainstem, infarction of
brainstem, lesion of
call 911
cardioseal device
cardiovascular disease
carotid angiogram
carotid artery disease
carotid artery disease, medical management
carotid artery occlusion, intracranial
carotid artery occlusion, neck
carotid artery stenosis
carotid artery stenosis, intracranial
carotid-siphon stenosis
CASSISS trial
CAT scan
CAT scan, abnormal
CAT scan, angiography
CAT scan, contrast extravasation
CAT scan, dense artery sign
CAT scan, mismatch between cerebral blood volume/flow
CAT scan, mismatch between perfusion/diffusion
CAT scan, perfusion
cerebellar infarction
cerebral atherosclerosis
cerebral atherosclerosis, medical management
cerebral embolism
cerebral embolism, mechanical extraction
cerebral infarction
cerebral infarction, hemorrhagic
cerebral infarction, small, deep
cerebral ischemia
cerebral venous infarction
cerebral venous thrombosis
cerebral venous thrombosis, etiology
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, adolescent
cerebrovascular accident, age of lesion
cerebrovascular accident, anticoagulant treatment
cerebrovascular accident, awakening with
cerebrovascular accident, cardiac disease causing
cerebrovascular accident, classification
cerebrovascular accident, complications with
cerebrovascular accident, cost of
cerebrovascular accident, delay in treatment
cerebrovascular accident, etiology
cerebrovascular accident, infancy and childhood
cerebrovascular accident, large
cerebrovascular accident, large ischemic core
cerebrovascular accident, nonarterial territory
cerebrovascular accident, nontreatment of
cerebrovascular accident, pathophysiology
cerebrovascular accident, platelet inhibiting drugs in treatment
cerebrovascular accident, prehospital screening
cerebrovascular accident, prehospital treatment
cerebrovascular accident, prevention of
cerebrovascular accident, primary prevention
cerebrovascular accident, prognosis in
cerebrovascular accident, racial differences
cerebrovascular accident, recurrent
cerebrovascular accident, rehabilitation of
cerebrovascular accident, secondary prevention
cerebrovascular accident, severity
cerebrovascular accident, sex distribution
cerebrovascular accident, surgical treatment of
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, thromobolytic agents in treatment, early dramatic recovery
cerebrovascular accident, time of onset
cerebrovascular accident, time of presentation
cerebrovascular accident, time to treatment
cerebrovascular accident, unknown time of onset
cerebrovascular accident, volume
cerebrovascular accident, women
cerebrovascular accident, work up for
cerebrovascular accident, young adult
cerebrovascular disease
cerebrovascular disease, risk factors in
cerebrovascular disease, treatment of
CHADS-VaSC score
CHANCE Trial
CHOICE trial
cholesterol
citicoline
clinical mismatch
Clinical Pathologic Conference(C.P.C.)
clinical trials
clopidogrel
CLOSURE I trial
clot retrieval
collateral circulation
color desaturation
coma
complications
controversies in neurology
coronavirus
cortical infarction, small
cortical vein thrombosis
cost
cost effectiveness
coumarin
COVID-19
craniectomy, decompressive
critical pathway
dabigatran
dabigatran, dose
DAWN stroke trial
decerebrate posture
DEFUSE study
dense basilar artery sign
dense middle cerebral artery sign
diplopia
dipyridamole
disability rating scale, neurological
disability, neurological
diuretic
dizziness
doll's head maneuver
door to imaging time
door to needle time
door to reperfusion time
door to treatment time
drop attacks
dural sinus thrombosis
dysarthria
edema, facial
efficacy
embolic stroke of unknown source
embolism
embolism, paradoxical
embolism, vertebral-basilar artery
emergencies, neurologic
emergency medical technicians
endarterectomy, carotid
endarterectomy, carotid-indications for
endovascular photoacoustic recanalization
endovascular therapy
endovascular therapy, late time window
endovascular therapy, selection criteria
endovascular therapy, time window
epidemic
epidemiology of neurology
EPITHET trial
ESCAPE trial
ethics in neurology
EXTEND trial
factor Xa inhibitor
failed medical management
fibrinolytic agents
fibrinolytic agents, combined IA and IV
fibrinolytic agents, complications
fibrinolytic agents, contraindications
fibrinolytic agents, intra-arterial local infusion
fibrinolytic agents, intra-venous local infusion
fibrinolytic therapy, selection criteria
fibrinolytic therapy, timing of administration
fibroblast growth factor
gastrointestinal bleeding
gaze palsy
gender
GOLIATH trial
HAS-BLED score
head injury
headache
headache, thunderclap
hemorrhagic diathesis
heparin
heparin, low-molecular-weight
hepatic failure
heprain induced thrombocytopenia
HERMES
herpes simplex encephalitis, diagnosis of
hospital length of stay
hypercoagulable state
hyperintense vessel sign
hypertension
iatrogenic neurologic disorders
idarucizumab
indapamide
informed consent
INR value, time in range
INR values
internal carotid artery
intracerebral hemorrhage
intracranial hemorrhage
intracranial pressure, increased
ischemic core
ischemic penumbra
lawsuit
lipid lowering agent
lipids
liver disease
liver function enzymes
locked-in syndrome
malpractice
mastoiditis
MATCH trial
medical-legal aspects of neurology
MERCI trial
middle cerebral artery
middle cerebral artery atherosclerosis
middle cerebral artery territory infarction
middle cerebral artery, branch occlusion
middle cerebral artery, occlusion of
middle cerebral artery, stenosis of
misdiagnosis
mobile interventional stroke teams
mortality
MR CLEAN
MR WITNESS trial
MRI
MRI, abnormal
MRI, CAT scan compared to
MRI, cerebrovascular disease
MRI, diffusion weighted
MRI, early changes in CVA
MRI, FLAIR, hyperintense vessels
MRI, mismatch between DWI/FLAIR
MRI, mismatch between perfusion/diffusion
MRI, perfusion
MRI, volumetry
multimodal neuroimaging
neoplasm, intracranial-incidence and epidemiology of
neurologic consultation
neurologic disease, diagnoses of
neurologic examination, focal
neurologic recovery
neurologic signs
neurologic symptoms
neuroprotective agents
neuroradiology, interventional
NIH stroke scale
NMDA antagonists
non-vitamin K antagonist oral anticoagulants
nystagmus
old age, neurology of
outcome research
palliative care
patent foramen ovale
patent foramen ovale, percutaneous closure
patient information and support
patient selection
Penumbra System
perindopril
platelet inhibiting drugs
platelet inhibiting drugs, combined
POINT trial
pons, infarction of
posterior cerebral artery occlusion
posterior circulation stroke
practice guidelines
prevention of neurologic disorders
PROFESS trial
prognosis
PROGRESS trial
quality of life
ramipril
Rankin score
RAPID CT perfusion maps
recanalization, arterial
recanalization, venous
recurrent
rehabilitation for neurologic disorders
RELY trial
reperfusion
research
RESPECT trial
Retriever Device
REVASCAT trials
revascularization, surgical
review article
risk factors
risk factors, modification
risk-benefit assessment
rivaroxaban
ROCKET - AF trial
safety
screening
seizure
seizure, focal
serum alanine aminotransferase
solitaire device
SPARCL trial
SPORTIF trial
STARFlex septal closure system
statin therapy
stent, carotid artery
stent, coronary artery
stent, intracranial
stent, middle cerebral artery
stent, vertebral artery
streptokinase
stroke center
stroke disability scale
stroke protocol
stroke unit, mobile
subarachnoid hemorrhage
subdural hematoma
superior sagittal sinus thrombosis
SWIFT PRIME Trials
SWIFT trial
symptomatic
T lesion of MCA-ICA
telemedicine
teleneurology
telestroke
tenecteplase
thrombectomy
thrombectomy, distal occlusion
thrombin inhibitor
thromboaspiration
thrombolysis, mechanical
time is brain
TIMELESS trial
tissue plasminogen activator, intravenous
transient ischemic attack
transient ischemic attack, treatment of
transluminal angioplasty, basilar artery
transluminal angioplasty, carotid artery
transluminal angioplasty, intracranial
transluminal angioplasty, intracranial-indications for
transluminal angioplasty, middle cerebral artery
transluminal angioplasty, vertebral artery
transport of patient
trauma
treatment delay
treatment of neurologic disorder
Trevo retriever
trial design
unconsciousness
unconsciousness, transient
urokinase
vaccination, neurologic complications with
vaccine
vertebral artery
vertebral artery occlusion
vertebral artery stenosis
vertebral-basilar artery, atherosclerosis
vertebral-basilar artery, intraluminal clot
vertebral-basilar insufficiency
vertigo
vision, blurred
VISSIT trial
visual field defect
WAKE-UP trial
WASID trial
weakness, generalized
Wingspan study
workup
ximelagatran
Showing articles 950 to 1000 of 2192 << Previous Next >>

Comparison of Tissue Plasminogen Activator Administration Management Between Telestroke Network Hospitals and Academic Stroke Centers
Stroke 37:1822-1827, Audebert,H.,et al, 2006

Hyperbaric Oxygen Therapy for Acute Ischemic Stroke
Stroke 37:1953-1954, Bennett,M.H.,et al, 2006

Previous Use of Aspirin and Baseline Stroke Severity: An Analysis of 17850 Patients in the International Stroke Trial
Stroke 37:1737-1740, Ricci,S.,et al, 2006

Thrombolysis (Tissue Plasminogen Activator) in Stroke: A Medicolegal Quagmire
Stroke 37:1917-1922, Weintraub,M.I., 2006

Door to Thrombolysis: ER Reorganization and Reduced Delays to Acute Stroke Treatment
Neurol 67:334-336, Lindsberg,P.J.,et al, 2006

Intravenous Recombinant Tissue Plasminogen Activator in a Pregnant Woman With Cardioembolic Stroke
Stroke 37:2168-2169, Wiese,K.M.,et al, 2006

Piracetam for Acute Ischemic Stroke
Stroke 37:2191-2192, Ricci,S.,et al, 2006

Premenstrual Multiple Sclerosis Pseudoexacerbations: Role of Body Temperature and Prevention With Aspirin
Arch Neurol 63:1005-1008, Wingerchuk,D.M. &Rodriguez,M., 2006

Factors Predicting Prognosis After Decompressive Hemicraniectomy for Hemispheric Infarction
Neurol 67:891-893, Rabinstein,A.A.,et al, 2006

Intra-Arterial Thrombolysis Is the Treatment of Choice for Basilar Thrombosis: Pro
Stroke 37:2436-2437,2440, Schellinger,P.D. &Hacke,W., 2006

Intra-Arterial Thrombolysis Is the Treatment of Choice for Basilar Thrombosis: Con
Stroke 37:2438-2439,2440, Ford,G.A., 2006

Tandem Internal Carotid Artery/Middle Cerebral Artery Occlusion: An Independent Predictor of Poor Outcome After Systemic Thrombolysis
Stroke 37:2301-2305, Rubiera,M.,et al, 2006

Antiplatelets, ACE Inhibitors, and Statins Combination Reduces Stroke Severity and Tissue At Risk
Neurol 66:1153-1158, Kumar,S.,et al, 2006

Long-Term Mortality After Intracerebral Hemorrhage
Neurol 66:1182-1186, Flaherty,M.I.,et al, 2006

Is IV Tissue Plasminogen Activator Beneficial in Patients With Hyperdense Artery Sign?
Neurol 66:1171-1174, Qureshi,A.I.,et al, 2006

Reasons Why Few Patients With Acute Stroke Receive Tissue Plasminogen Activator
Arch Neurol 63:661-664, Bambauer,K.Z.,et al, 2006

Aspirin Plus Dipyridamole Versus Aspirin Alone After Cerebral Ischaemia of Arterial Origin (ESPRIT): Randomised Controlled Trial.
Lancet 367:1665-1673,1638, The ESPRIT Study Group, 2006

Primary Prevention of Ischemic Stroke
Stroke 37:1583-1633, Goldstein,L.B.,et al, 2006

Clinicopath Conf, Acute Ischemic Stroke
NEJM 354:2263-2271, Case 16:2006, 2006

Community Socioeconomic Status and Prehospital Times in Acute Stroke and Transient Ischemic Attack
Stroke 37:1508-1513,1354, Kleindorfer,D.O.,et al, 2006

Major Congential Malformations After First-Trimester Exposure to ACE Inhibitors
NEJM 354:2443-2451,2498, Cooper,W.O.,et al, 2006

Thrombolysis in Patients Older Than 80 Years With Acute Ischaemic Stroke: Canadian Alteplase for Stroke Effectiveness Study
JNNP 77:826-829,812, Sylaja, P.N.,et al, 2006

Clopidogrel Plus Aspirin Versus Oral Anticoagulation for Atrial Fibrillation in the Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events (ACTIVE W): A Randomised Controlled Trial
Lancet 367:1903-1912,1877, The ACTIVE Writing Group on behalf of the ACTIVE Investigators, 2006

Intracerebral Hemorrhage Associated with Oral Anticoagulant Therapy
Stroke 37:256-262, Steiner, T.,et al, 2006

Regular Aspirin -Use Preceding the Onset of Primary Intracerebral Hemorrhage is an Independent Predictor for Death
Stroke 37:129-133,4, Saloheimo,P.,et al, 2006

Antiplatelet Therapy for Preventing Stroke in Patients With Nonvalvular Atrial Fibrillation and No Previous History of Stroke or Transient Ischemic Attacks
Stroke 37:274-275, Aguilar,M.I. &Hart,R.G., 2006

Mechanical Thrombolysis in Ischemic Stroke Attributable to Basilar Artery Occlusion as First-Line Treatment
Stroke 37:145-150, Bergui,M.,et al, 2006

Time Is Brain--Quantified
Stroke 37:263-266,10, Saver,J.L., 2006

Urgent Clinical Challenges in Children With Ischemic Stroke
Stroke 37:116-122,3, Kuhle,S.,et al, 2006

Timing of Fresh Frozen Plasma Administration and Rapid Correction of Coagulopathy in Warfarin-Related Intracerebral Hemorrhage
Stroke 37:151-155,6, Goldstein,J.N.,et al, 2006

Self-Monitoring of Oral Anticoagulation: A Systematic Review and Meta-Analysis
Lancet 367:404-411,412, Heneghan,C.,et al, 2006

Classification and Pathogenesis of Cerebral Hemorrhages After Thrombolysis in Ischemic Stroke
Stroke 37:556-561, Trouillas,P. &von Kummer,R., 2006

Cerebral Microhemorrhage
Stroke 37:550-555, Viswanathan,A. &Chabriat,H., 2006

Factors Associated With In-Hospital Mortality After Administration of Thrombolysis in Acute Ischemic Stroke Patients, An Analysis of the Nationwide Inpatient Sample 1999 to 2002
Stroke 37:440-446, Bateman,B.T.,et al, 2006

Perfusion CT Helps Decision Making for Thrombolysis When There is No Clear Time of Onset
JNNP 77:417-419, Hellier,K.D.,et al, 2006

Thrombolysis for Acute Stroke with Special Emphasis on the Very Old:Experience From a Single Dutch Centre
JNNP 77:375-377,288, van Oostenbrugge,R.J.,et al, 2006

Outcome and Symptomatic Bleeding Complications of Intravenous Thrombolysis Within 6 Hours in MRI-Selected Stroke Patients
Stroke 37:852-858, Thomalla,G.,et al, 2006

Therapeutic Strategies After Examination by Transesophageal Echocardiography in 503 Patients with Ischemic Stroke
Stroke 37:859-864, Harloff,A.,et al, 2006

Role of CT Angiography in Thrombolysis Decision-Making for Patients with Presumed Seizure at Stroke Onset
Stroke 37:915-917, Sylaja,P.N.,et al, 2006

Therapy of Basilar Artery Occlusion, A Systematic Analysis Comparing Intra-Arterial and Intravenous Thrombolysis
Stroke 37:922-928, Lindsberg,P.J.&Mattle,H.P., 2006

Management of Antiphospholipid Antibody Syndrome, A Systematic Review
JAMA 295:1050-1057, Lim,W.,et al, 2006

Thrombolytic Therapy of Acute Ischemic Stroke During Pregnancy
Neurol 66:768-770, Murugappan,A.,et al, 2006

The Risks and Safety of Clopidogrel in Pediatric Arterial Ischemic Stroke
Stroke 37:1120-1122, Soman,T.,et al, 2006

Extent of Early Ischemic Changes on Computed Tomgraphy (CT) Before Thrombolysis
Stroke 37:973-978, Dzialowski,I.,et al, 2006

Imaging-Guided Acute Ischemic Stroke Therapy: From "Time is Brain" to "Physiology is Brain"
AJNR 27:728-735, Gonzalez,R.G., 2006

Statin-Associated Myasthenia Gravis
Medicine 85:82-85, Purvin,V.,et al, 2006

Clopidogrel and Aspiring versus Aspirin Alone for the Prevention of Atherothrombotic Events
NEJM 354:1706-1717,1744, Bhatt,D.L.,et al, 2006

Poststroke C-Reactive Protein Is a Powerful Prognostic Tool Among Candidates for Thrombolysis
Stroke 37:1205-1210, Montaner,J.,et al, 2006

Not All Patients With Atrial Fibrillation-Associated Ischemic Stroke Can Be Started on Anticoagulant Therapy
Stroke 37:1217-1220, Somerfield,J.,et al, 2006

Good Outcomes in Ischemic Stroke Patients treated With Intravenous Thrombolysis Despite Regressing Neurological Symptoms
Stroke 37:1332-1333, Baumann,C.R.,et al, 2006



Showing articles 950 to 1000 of 2192 << Previous Next >>